Who
Neal Flomenberg
Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Tevogen.
In numbers
- Trades disclosed
- 16
- Buys
- 0
- Sells
- 11
- Bought
- $0
- Sold
- $2.5M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 14 Feb 2024
- Last trade
- 13 Mar 2026
- Last filed
- 17 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 13 Mar 2026filed 17 Mar 2026 | TVGN TevogenBiotechnology | SEC FORM 4 Sold | $3,206501 at $6.40 | filing |
| 13 Mar 2026filed 17 Mar 2026 | TVGN TevogenBiotechnology | SEC FORM 4 Sold | $3,206501 at $6.40 | filing |
| 11 Mar 2026filed 17 Mar 2026 | TVGN TevogenBiotechnology | SEC FORM 4 Sold | $3,282452 at $7.26 | filing |
| 11 Mar 2026filed 17 Mar 2026 | TVGN TevogenBiotechnology | SEC FORM 4 Sold | $3,282452 at $7.26 | filing |
| 10 Mar 2026filed 17 Mar 2026 | TVGN TevogenBiotechnology | SEC FORM 4 Sold | $14719 at $7.75 | filing |
| 10 Mar 2026filed 17 Mar 2026 | TVGN TevogenBiotechnology | SEC FORM 4 Sold | $14719 at $7.75 | filing |
| 27 Jun 2025filed 1 Jul 2025 | TVGN TevogenBiotechnology | SEC FORM 4 Code A | —300,000 at $0.00 | filing |
| 12 Mar 2025filed 14 Mar 2025 | TVGN TevogenBiotechnology | SEC FORM 4 Sold | $254K232,968 at $1.09 | filing |
| 11 Mar 2025filed 11 Mar 2025 | TVGN TevogenBiotechnology | SEC FORM 4 Sold | $74K70,252 at $1.05 | filing |
| 10 Mar 2025filed 11 Mar 2025 | TVGN TevogenBiotechnology | SEC FORM 4 Sold | $77K70,384 at $1.09 | filing |
| 7 Mar 2025filed 11 Mar 2025 | TVGN TevogenBiotechnology | SEC FORM 4 Sold | $81K71,273 at $1.14 | filing |
| 6 Mar 2025filed 6 Mar 2025 | TVGN TevogenBiotechnology | SEC FORM 4 Sold | $97K88,519 at $1.10 | filing |
| 5 Mar 2025filed 6 Mar 2025 | TVGN TevogenBiotechnology | SEC FORM 4 Sold | $134K110,659 at $1.21 | filing |
| 4 Mar 2025filed 6 Mar 2025 | TVGN TevogenBiotechnology | SEC FORM 4 Sold | $19K14,639 at $1.28 | filing |
| 17 Oct 2024filed 18 Oct 2024 | TVGN TevogenBiotechnology | SEC FORM 4 Sold | $1.7M1,078,600 at $1.62 | filing |
| 14 Feb 2024filed 16 Feb 2024 | TVGN TevogenBiotechnology | SEC FORM 4 Code A | —5,332,902 | filing |
News
No headline names them, or the companies they trade most, lately.